Healthcare Market Research Reports & Industry Analysis
MarketResearch.com provides detailed reports for various countries around the world and the healthcare needs and offerings in those countries. These reports also profile the types of administrations and regulations and policies that are in place in various regions and segments in each country.
Reports are available in industry sub-categories such as: wellness and preventative programming, sports medicine, insurance and managed care, and clinical guidelines and best practices. Readers may also find data regarding alternative and complementary medicine, nursing, public health and information technology. Though not always considered when first thinking of healthcare, information may also be found on veterinary health.
Reviews of various equipment and pharmaceuticals in specific regions are made available regarding multiple countries. Herbal and traditional products are contrasted and compared, and global access to sufficient ambulance services is discussed.
Healthcare Industry Research & Market Reports
-
Micro-Location Technology Market by Application (Asset Management, Proximity Marketing), Technology (BLE, UWB, Wi-Fi, RFID), Offering, Vertical (Retail and Hospitality, Healthcare, Industrial, Transportation, Sports), & Geography - Global Forecast to 2024
... grow at 19.4% CAGR during 2019–2024” The micro-location technology market is projected to grow from USD 14.1 billion in 2019 to USD 34.1 billion by 2024 at a CAGR of 19.4%. Increasing importance of asset ... Read More
-
Bulgaria Pharmaceuticals & Healthcare Q2 2019
... to improve the quality and capacity of Bulgaria's healthsystem. However, recent protests over the lack of transparency on the setting of pharmaceutical contracts and the failure tonormalise the drugs supply highlight the growing need for ... Read More
-
Hospitals, Medical and Dental Services in Mexico
... Hospitals, Medical and Dental Services market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers ... Read More
-
El Salvador Pharmaceuticals & Healthcare Q2 2019
... slow but steady improvement to pharmaceutical production infrastructureand intellectual property provisions. However, owing to a persistent lack of coordination, underdeveloped informationsystems and financial instability, the health sector has been unable to exploit the country's abundant ... Read More
-
Estonia Pharmaceuticals & Healthcare Q2 2019
... which will repress long-term opportunities.Nonetheless, we expect the government’s increased healthcare funding over the coming years - following historically inadequatelevels – will improve patient access to healthcare and boost drugmaker prospects in the short and ... Read More
-
Nicaragua Pharmaceuticals & Healthcare Q2 2019
... and long-term, the sector will remain heavily underfunded. Withthe government cutting funding for numerous healthcare projects along with the mass dismissals of medical professionals inretaliation to wide spread unrest in 2018, patient access to health ... Read More
-
Slovakia Pharmaceuticals & Healthcare Q2 2019
... while corruption and the use of bribes seemsto be on the decline, the Slovak healthcare system is still struggling with certain aspects, including the provision of adequatefunding and keeping the lid on patient co-payment increases. Read More
-
Europe Pharmaceuticals & Healthcare Q2 2019
... to region-specific trends. Themore developed Western markets will continue to be favoured by innovative drugmakers due to stronger regulatory oversight andgreater purchasing power, although growth in these markets will be suppressed by aggressive cost-containment. Revenue ... Read More
-
Ghana Pharmaceuticals & Healthcare Q2 2019
... has led to difficulties doingbusiness, including high operational costs for foreign companies. While Ghana is positioned as one of the more attractivepharmaceutical markets for multinational firms on a regional basis, generic products will maintain a ... Read More
-
Guatemala Pharmaceuticals & Healthcare Q2 2019
... constraints will remain a recurrent issue. This will bepartially addressed by new healthcare infrastructure projects announced by the social security institute. Government steps towardsunifying the health system will progress at a gradual pace, limiting significant ... Read More
-
Veterinary Services in Mexico
... at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing ... Read More
-
Netherlands Pharmaceuticals & Healthcare Q2 2019
... under the Medicines Prices Act. We expect innovative drug sales will continueto decline in the short term, with growth in this sub-sector returning over the longer term as the population ages and chronicillnesses rise. However, ... Read More
-
Kenya Pharmaceuticals & Healthcare Q2 2019
... access to and qualityof services. Additionally, wealthier urban pockets represent a potential market for multinationals that offer high-value medicines .However, per capita spending on both pharmaceuticals and healthcare remains modest in comparison with similar Asian ... Read More
-
Industrial and Laboratory Furnaces in Mexico
... and Laboratory Furnaces market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis ... Read More
-
Latin America Pharmaceuticals & Healthcare Q2 2019
... multinational pharmaceutical firms with a risingburden of chronic diseases and increasing access to healthcare services. However, in the short term, growth opportunities in theregion's major markets will be repressed by significant political and economic risks. Read More
-
Gabon Pharmaceuticals & Healthcare Q2 2019
... and the lack of public sector funding continue to hamper their commercial potential, despite thegradually rising demand. The growing population number and the increased incidence of civilisation diseases will still offer fewopportunities innovative medicines drugmakers. Read More
-
Kyrgyzstan Pharmaceuticals & Healthcare Q2 2019
... unified medicine registration system in the Eurasian Economic Unionwill support access to medicines; however, major barriers - such as the prevalence of counterfeit medicines and challenges in supplyand distribution across the country - will remain. Read More
-
Serbia Pharmaceuticals & Healthcare Q2 2019
... a strong growthprospect on a regional basis, particularly within the generic medicine sector. However, Serbia's pharmaceutical market will remain arelatively high-risk market for innovative drugmakers on account of low affordability levels, weak access to healthcare ... Read More
-
Asia Pharmaceuticals & Healthcare Q2 2019
... However, these markets will no longer providesignificant revenue growth due to aggressive cost containment. Instead, growth opportunities will be plentiful in emerging markets.We note that due to continued regulatory challenges and a growing focus on ... Read More
-
Brazil Pharmaceuticals & Healthcare Q2 2019
... remain a highly challenging market. A restriction onpublic healthcare expenditure will place additional pressures on medicine prices while schemes to control prices and boost localcapacity will further dissuade foreign investment. Of the four BRICs markets, ... Read More
-
Sub-Saharan Africa Pharmaceuticals & Healthcare Q2 2019
... within the generic medicines sector, while the larger more developed marketspresent viable opportunities for patented medicine sales in urban regions. Cooperative agreements with international firms willprovide opportunities for domestic firms to expand their manufacturing capacities. Read More
-
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan
... information and analysis on the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Japan. ... Read More
-
Global Transfusion Diagnostics Market 2019-2023: Country Shares, Volume and Sales Forecasts for Typing, Grouping and Infectious Disease Screening/NAT Assays, Laboratory Universe
... of facilities performing transfusion testing tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. Contains 15 pages and 5 tables Please note: ... Read More
-
Vietnamese Clinical Laboratories Market, Forecast to 2025
... to reduce healthcare spending is shifting healthcare application in favor of the laboratory, making it a more valuable part of the treatment plan. Vietnam CLT market is growing at a healthy rate, driven by plans ... Read More
-
Ambulatory Health Care Services
... companies include Apria Healthcare, DaVita, and LabCorp (all based in the US), as well as Bayshore HealthCare (Canada), Fresenius (Germany), and Sonic Healthcare (Australia). COMPETITIVE LANDSCAPE Pressure on the health care industry to drive down ... Read More
